These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Memantine reduces the production of amyloid-β peptides through modulation of amyloid precursor protein trafficking. Ito K; Tatebe T; Suzuki K; Hirayama T; Hayakawa M; Kubo H; Tomita T; Makino M Eur J Pharmacol; 2017 Mar; 798():16-25. PubMed ID: 28167259 [TBL] [Abstract][Full Text] [Related]
4. Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. Furukawa K; Sopher BL; Rydel RE; Begley JG; Pham DG; Martin GM; Fox M; Mattson MP J Neurochem; 1996 Nov; 67(5):1882-96. PubMed ID: 8863493 [TBL] [Abstract][Full Text] [Related]
5. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695. Peng Y; Lee DY; Jiang L; Ma Z; Schachter SC; Lemere CA Neuroscience; 2007 Dec; 150(2):386-95. PubMed ID: 17945434 [TBL] [Abstract][Full Text] [Related]
6. Melatonin affects the metabolism of the beta-amyloid precursor protein in different cell types. Lahiri DK J Pineal Res; 1999 Apr; 26(3):137-46. PubMed ID: 10231726 [TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide inhibits A2A adenosine receptor agonist induced β-amyloid production in SH-SY5Y neuroblastoma cells via a cAMP dependent pathway. Nagpure BV; Bian JS PLoS One; 2014; 9(2):e88508. PubMed ID: 24523906 [TBL] [Abstract][Full Text] [Related]
8. Identification of novel small molecule inhibitors of amyloid precursor protein synthesis as a route to lower Alzheimer's disease amyloid-beta peptide. Utsuki T; Yu QS; Davidson D; Chen D; Holloway HW; Brossi A; Sambamurti K; Lahiri DK; Greig NH; Giordano T J Pharmacol Exp Ther; 2006 Aug; 318(2):855-62. PubMed ID: 16690718 [TBL] [Abstract][Full Text] [Related]
9. Serum is required for release of Alzheimer's amyloid precursor protein in neuroblastoma cells. Villa A; Santiago J; García-Silva S; Ruiz-León Y; Pascual A Neurochem Int; 2002 Oct; 41(4):261-9. PubMed ID: 12106777 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of piperlonguminine/ dihydropiperlonguminine on the production of amyloid beta and APP in SK-N-SH cells. Qi HS; Liu P; Gao SQ; Diao ZY; Yang LL; Xu J; Qu X; Han EJ Chin J Physiol; 2009 Jun; 52(3):160-8. PubMed ID: 19777802 [TBL] [Abstract][Full Text] [Related]
11. Tenuigenin treatment decreases secretion of the Alzheimer's disease amyloid beta-protein in cultured cells. Jia H; Jiang Y; Ruan Y; Zhang Y; Ma X; Zhang J; Beyreuther K; Tu P; Zhang D Neurosci Lett; 2004 Aug; 367(1):123-8. PubMed ID: 15308312 [TBL] [Abstract][Full Text] [Related]
13. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease. Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868 [TBL] [Abstract][Full Text] [Related]
14. Activity of alpha-secretase as the common final effector of protein kinase C-dependent and -independent modulation of amyloid precursor protein metabolism. Racchi M; Solano DC; Sironi M; Govoni S J Neurochem; 1999 Jun; 72(6):2464-70. PubMed ID: 10349856 [TBL] [Abstract][Full Text] [Related]
15. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models. Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932 [TBL] [Abstract][Full Text] [Related]
16. APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells. De Chiara G; Marcocci ME; Civitelli L; Argnani R; Piacentini R; Ripoli C; Manservigi R; Grassi C; Garaci E; Palamara AT PLoS One; 2010 Nov; 5(11):e13989. PubMed ID: 21085580 [TBL] [Abstract][Full Text] [Related]
17. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein. Harris B; Pereira I; Parkin E Brain Res; 2009 Nov; 1296():203-15. PubMed ID: 19679113 [TBL] [Abstract][Full Text] [Related]
18. Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice shown as by micromagnetic resonance imaging. Scholtzova H; Wadghiri YZ; Douadi M; Sigurdsson EM; Li YS; Quartermain D; Banerjee P; Wisniewski T J Neurosci Res; 2008 Sep; 86(12):2784-91. PubMed ID: 18615702 [TBL] [Abstract][Full Text] [Related]
19. A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity. Hashimoto Y; Matsuoka M J Neurochem; 2014 Jul; 130(2):291-300. PubMed ID: 24646423 [TBL] [Abstract][Full Text] [Related]
20. Nicotine reduces the secretion of Alzheimer's beta-amyloid precursor protein containing beta-amyloid peptide in the rat without altering synaptic proteins. Lahiri DK; Utsuki T; Chen D; Farlow MR; Shoaib M; Ingram DK; Greig NH Ann N Y Acad Sci; 2002 Jun; 965():364-72. PubMed ID: 12105112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]